{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-014541","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2025-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.476370+00:00","generated_at":"2026-05-24T07:36:08.682189+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"BioLife appoints Cathy Coste to board as director and audit committee chair","bullets":["Effective March 18, 2025, Catherine Coste appointed to board, replacing Joydeep Goswami as audit committee chair.","Coste brings over 30 years at Deloitte as senior partner and life sciences industry leader.","She will serve until 2025 Annual Meeting and receive standard non-employee director compensation.","Board expanded to seven members; Coste independent under SEC and Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-014541","json":"https://secwatch.observer/filing/0001628280-25-014541.json","markdown":"https://secwatch.observer/filing/0001628280-25-014541.md","text":"https://secwatch.observer/filing/0001628280-25-014541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014541/0001628280-25-014541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014541/blfs-20250318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T07:36:08.682189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"750df1d35c","claim":"Catherine Coste was appointed as Director and Audit Committee Chair at BIOLIFE SOLUTIONS INC.","evidence_excerpt":"Effective March 18, 2025, the board of directors (the “Board”) of BioLife Solutions, Inc. (the “Company”) appointed Catherine Coste to serve as a member of the Board until the Company’s 2025 Annual Meeting of Stockholders","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/834365/000162828025014541/0001628280-25-014541-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director and Audit Committee Chair"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}